Boston Scientific (BSX) Deferred Taxes (2020 - 2026)

Boston Scientific has disclosed Deferred Taxes across 7 years of filings, most recently posting $17.0 million for Q2 2026.

• In Q2 2026, Deferred Taxes rose 118.89% year-over-year to $17.0 million; the TTM figure through Jun 2026 stood at -$297.0 million (down 85.62% YoY), while the FY2025 annual figure was -$12.0 million, up 86.67% from the prior year.
• Deferred Taxes came in at $17.0 million for Q2 2026 at Boston Scientific, up from -$351.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $147.0 million in Q4 2023 to a low of -$351.0 million in Q1 2026.
• Average Deferred Taxes over 5 years is -$23.7 million, with a median of -$10.5 million recorded in 2024.
• Year-over-year, Deferred Taxes plunged 7400.0% in 2022 and soared 2000.0% in 2023.
• Over 5 years, Deferred Taxes stood at $7.0 million in 2022, then soared by 2000.0% to $147.0 million in 2023, then sank by 168.03% to -$100.0 million in 2024, then jumped by 68.0% to -$32.0 million in 2025, then soared by 153.12% to $17.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were $17.0 million in Q2 2026, -$351.0 million in Q1 2026, and -$32.0 million in Q4 2025.